why is POAI down over 90% in the past 5 years

The significant decline in POAI's stock price over the past five years can be attributed to several factors:

1. Inaccurate Predictions: The company's stock experienced a sharp decline due to the inaccurate predictions made by its AI-driven platform. This led to a loss of investor confidence and a decrease in the stock's value.
2. Market Dynamics: The broader market conditions and investor sentiment also played a role in the decline. The biotechnology sector can be volatile, and market trends can quickly shift, affecting stock prices.
3. Failure to Deliver on Promises: Predictive Oncology's stock dropped over 50% at the start of the year, which reflects a loss of investor confidence due to the company's inability to deliver on its promises.

In summary, the decline in POAI's stock price over the past five years is a result of a combination of inaccurate predictions, market dynamics, and failure to deliver on promises.